The efficacy and safety of evinacumab in homozygous familial hypercholesterolaemia (HoFH) patients with little to no low-density lipoprotein receptor (LDLR) activity
- Resource Type
- Abstract
- Source
- In
Atherosclerosis December 2020 315:e8-e8 - Subject
- Language
- ISSN
- 0021-9150